跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VINORELBINE INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VINORELBINE INJECTION, USP
Authorized
STANDARD
VINORELBINE INJECTION, USP
FRESENIUS KABI CANADA LTD
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
0e3fa5a16d19bd89
Company
FRESENIUS KABI CANADA LTD
Type
Standard
Approval Details
Approval Id
0e3fa5a16d19bd89
Drug Approval Canada Name
VINORELBINE INJECTION, USP
Product Name
VINORELBINE INJECTION, USP
Status
Marketed
Status Date
2021-06-25
Original Market Date
2021-06-25
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
PRESCRIPTION
Ahfs
10:00.00
Atc Original
L01CA04 VINORELBINE
Aig Number
0126071001
Company Name
FRESENIUS KABI CANADA LTD
Company Address
165 Galaxy Blvd, Suite 100 Toronto Ontario Canada M9W 0C8
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
0e3fa5a16d19bd89
Type
Standard
Back to Health Canada Approvals